When myelin breaks, tau aggregates - a new perspective on Alzheimer's disease.
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical perspective paper proposing a mechanistic framework without new empirical data.
PubMed 42619321 · doi:10.1002/alz.71774
What was done
The authors synthesized existing literature to construct a theoretical, myelin-centered framework linking oligodendrocyte vulnerability and myelin breakdown to tau pathology and progression in Alzheimer's disease.
What was found
The abstract reports no primary experimental or quantitative data. It outlines three hypothesized mechanisms: (1) vulnerability of late-myelinating oligodendrocytes triggers metabolic stress and axonal dysfunction that promotes tau hyperphosphorylation; (2) microglial responses to myelin debris cause lipid overload that impairs tau clearance; and (3) oligodendrocytes serve as conditional reservoirs facilitating tau transmission across myelinated brain networks.
Why it matters
This perspective reframes Alzheimer's disease tau pathology around white matter biology, providing specific mechanistic hypotheses for how oligodendrocyte dysfunction could drive neurodegeneration and offering potential targets for future therapeutic exploration.
Limits
The paper presents a theoretical framework and narrative review without new experimental, animal, or human clinical data. The proposed tripartite mechanisms remain untested hypotheses within this article and require future experimental validation.
Cited by
- supports Loss of myelination by oligodendrocytes occurs in Alzheimer's disease.